This is a single institution phase II trial to determine the effectiveness of stem cells from closely matched related and unrelated donors to replace missing or defective proteins responsible for severe forms of epidermolysis bullosa.
The focus of the consultation is to inform you of the results of therapy to date. The following information is required prior to your or your child's consultation:
Prior to knowing if you or your child meets all the eligibility requirements for the stem cell transplant procedure, you or your child will need to go through an evaluation. The screening visit will involve skin biopsies, blood tests, photographs, assessment of skin fragility, CT scans and consultation with specialists. In addition, the visit will entail review of the clinical history and detailed to review of what is known and unknown regarding the proposed treatment procedure using stem cell populations from an allogeneic donor.
Based on this information, you or your child may need additional evaluations (e.g., dermatology, surgery, gastroenterology).
Patty Kleinke, RN, BAN
Pediatric BMT Lead Nurse Clinician
Blood and Marrow Transplant Program